The increased levels of plasma MPO, neutrophil activation marker CD66b, and calprotectin, mainly originating from neutrophils, in individuals with obesity as compared to lean controls sustain the relationship between obesity and systemic activation of neutrophils [68]. The gene discussed is MPO; the disease is obesity disorder.